Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9L82
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,824
Award facts
- Contract value 100% obligated
- $16,823.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $16,823.76 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen auto-injectors on December 4, 2025. This firm fixed-price contract, with an ultimate completion date of December 5, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic immunosuppressant medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and asthma, making it a critical pharmaceutical for military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen maintains a comprehensive contract portfolio with the Defense Logistics Agency's Medical Supply Chain, supplying an extensive range of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs globally. The company's demonstrated capability in fulfilling federal medical procurement requirements through competitive awards positions it as a key vendor for the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9L82?
SPE2DR26F9L82 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26F9L82 worth?
The government has obligated $16,824 on SPE2DR26F9L82.
Is contract SPE2DR26F9L82 an order under another contract?
Yes. SPE2DR26F9L82 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9L82 competed?
The extent of competition for SPE2DR26F9L82 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award